Next Thursday, Oct. 20, is the last day shareholders can be on record for the upcoming rights offering. That offering is set to take place just a few days later on Oct. 24. Investors need to be on record to take part in the offering.
This offering will see Eargo offer up rights to purchase as much as 375 million shares at a subscription price of 50 cents per share. The company intends to generate $187.5 million in “aggregate gross proceeds” from this offering.
EAR Stock: What Will Happen to the Funds?
Eargo has already laid out its full plans for the money that it makes from the offering. The most important use will be the repayment of outstanding notes issued to Patient Square Capital. It intends to use a substantial amount of the money for this purpose.
For some background, Eargo entered into an agreement to issue those senior notes on June 28, 2022. This saw $100 million worth of notes issued to an affiliate of Patient Square. The agreement included approval from shareholders for the rights offering.
EAR stock is down 4.4% as of Friday afternoon.
Investors looking for more of the hottest stock market news will want to keep reading!
InvestorPlace has all of the latest stock market news traders need to know about for Friday! Among that is why shares of Castellum (NYSEMKT:CTM), Revlon (NYSE:REV) and UnitedHealth (NYSE:UNH) are in the news today. You can read up on all of that at the following links!
More Friday Stock Market News
- What Is Going on With Castellum (CTM) Stock Today?
- 5 Investors Betting Big on Revlon (REV) Stock
- UnitedHealth (UNH) Stock Pops on Raised Outlook
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.